The clinical effects of Nilvadipine in vertigo

Abstract

Nilvadipine, a selective calcium-entry blocker, was administered to 17 patients who presented with complaints of dizziness and vertigo for 4 weeks and the clinical efficacy was studied. The rate of general clinical efficacy was “good” in 65% and “fair” in 100%. In two patients with hypertension, this drug induced normal blood pressure, while in patients with normal blood pressure, no change in the blood pressure was observed. In addition, no side effects were seen.